Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry

Background: Asthma is one of the most common non-communicable respiratory diseases, affecting about 6% of the general population. Severe asthma, even if afflicts a minority of asthmatics, drives the majority of costs of the disease. The aim of this study is to create a pharmacoeconomic model to pred...

Full description

Bibliographic Details
Main Authors: Giorgio Walter Canonica, Giorgio Lorenzo Colombo, Giacomo Matteo Bruno, Sergio Di Matteo, Chiara Martinotti, Francesco Blasi, Caterina Bucca, Nunzio Crimi, Pierluigi Paggiaro, Girolamo Pelaia, Giovanni Passalaqua, Gianenrico Senna, Enrico Heffler, Aliberti Stefano, Bagnasco Diego, Barbuto Sarah, Camiciottoli Gianna, Caminati Marco, Colombo Giselda, Costantino Maria Teresa, Crimi Claudia, Crivellaro Mariangiola, D'Amato Mariella, Favero Elisabetta, Foschino Maria Pia, Guarnieri Gabriella, Latorre Manuela, Lombardi Carlo, Francesco Menzella, Patella Vincenzo, Puggioni Francesca, Ridolo Erminia, Rolla Giovanni, Savi Eleonora, Scichilone Nicola, Solidoro Paolo, Spadaro Giuseppe, Triggiani Massimo
Format: Article
Language:English
Published: Elsevier 2019-01-01
Series:World Allergy Organization Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455119300523